{"nct_id":"NCT06007690","title":"A Phase 3 Randomized, Masked, Controlled Trial to Evaluate Efficacy and Safety of Belzupacap Sarotalocan (AU-011) Treatment Compared to Sham Control in Subjects With Primary Indeterminate Lesions or Small Choroidal Melanoma","status":"RECRUITING","status_verified_date":"2025-09","start_date":"2023-12-06","start_date_type":"ACTUAL","primary_completion_date":"2026-03-01","primary_completion_date_type":"ESTIMATED","completion_date":"2027-03-01","completion_date_type":"ESTIMATED","phases":["PHASE3"],"tickers":["AURA"]}